The AGO Study Group designs and implements phase I-III multicentre clinical studies for all indications of pelvic tumours in women. The projects are usually designed as Investigator-Initiated Trials (IIT) and carried out in accordance with all national and international quality standards.

Our offer includes the competent and quick implementation of clinical trials concerning medicinal and surgical forms of therapy or other medicinal/surgical issues. We support our industrial and scientific partners from the planning phase through the completion of a study with comprehensive services. As the AGO Study Group is part of an international network of academically oriented study groups under the umbrella of the Gynaecologic Cancer Intergroup (GCIG), the integration of experienced study centres all over the world is another possible option.